The Future of AI & Personalized Cancer Care

The Future of AI and Personalized Cancer Care:

How can patient empowerment accelerate improved cancer outcomes?

The Future of AI and Personalized Cancer Care:

How can patient empowerment accelerate improved cancer outcomes?

We were honored to host an in-person, pre-ASCO Symposium where we brought together patients, practitioners, and experts in life sciences, digital health, policy, and advocacy to delve into the transformative power of generative AI in the delivery of cancer care.

Our June 2nd Agenda:

9:00am – 9:15am: Opening remarks by Dr. Maya R. Said, Founder and CEO, Outcomes4Me

9:15am – 9:45am: Keynote opening by Dr. Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca

9:45am – 10:30am: Panel 1: AI in support of delivering patient-centric, guideline-concordant cancer care

Dr. Crystal Denlinger, Chief Scientific Officer, NCCN®
Dr. V.K. Gadi, Deputy Director, University of Illinois Cancer Center
Dr. Aradhana Ghosh, VP, Oncology Informatics, Labcorp Oncology
Dr. Chadi Nabhan, SVP and Chairman, Caris Precision Oncology Alliance
Kimberly Richardson, President, Black Cancer Collaborative, patient advocate & cancer survivor
Dr. Maya Said, Founder and CEO, Outcomes4Me (moderator)

10:30am – 11:15am: Panel 2: The role of AI in advancing equitable clinical trial recruitment and access

Suzanne Garner, Stage II breast cancer survivor & NATALEE trial participant
Dr. Kyle Holen, SVP Head of Development, Therapeutics and Oncology, Moderna
Dr. Steven Isakoff, Associate Director, MGH Cancer Research
Dr. Prasanth Reddy, SVP, Global Enterprise Oncology Head, Labcorp
Dr. Maya Said, Founder and CEO, Outcomes4Me (moderator)

11:15am – 12:00pm: Panel 3: The value of AI-powered, direct-to-patient activation in the consumer privacy era

Dr. Grace Cordovano, BCPA, Founder, Enlightening Results
Dr. Debra Friedman, Associate Director, Community Science & Health Outcomes, Vanderbilt Ingram Cancer Center
Dr. Arun Krishna, VP Head of US Lung Cancer business, AstraZeneca
Susan Manber, Chief Patient Officer at Publicis Health
Brenna Fitzgerald, VP of Marketing & Communications, Outcomes4Me (moderator)

12:00pm – 12:15pm: Closing remarks

12:15pm – 1:00pm: Lunch & networking

Three important discussions

Panel 1: AI in support of delivering patient-centric, guideline-concordant cancer care

In the age of AI, oncologists now have an opportunity to leverage patient-reported outcomes and real-world data to drive guideline-concordant care. Join us as we explore AI’s role in supporting physician decision-making and its ability to, in turn, better serve patients.

Panel 2: The role of AI in advancing equitable clinical trial recruitment and access

Join us as our panel of experts and patient advocates discusses the role of AI & digital health solutions in equitable clinical trial recruitment and examine how AI-driven patient empowerment and self-advocacy can contribute to clinical-trial matching.

Panel 3: The value of AI-powered, direct-to-patient activation in the consumer privacy era

Explore how opt-in AI can empower patients with personalized, relevant information, and how this approach coupled with true patient ownership of their medical records will both support the pharmaceutical industry’s commercial goals but also better serve patients.